Literature DB >> 33685449

CTCF-silenced miR-137 contributes to EMT and radioresistance in esophageal squamous cell carcinoma.

Shuwen Xu1, Xiaofeng Li2, Longfei Li3, Yufeng Wang4, Chong Geng5, Feng Guo5, Tao Zhang5, Aonan Du5, Zhiwei Lu5, Hua Hui5, Qiang Wang6.   

Abstract

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is one of the most malignant tumors in gastrointestinal system. MicroRNAs (miRNAs) have been reported to be implicated in cancer development. However, the role of miR-137 has not been fully revealed in ESCC.
METHODS: Quantitative real-time polymerase chain reaction (qRT-PCR) and western blot analyses were separately used to examine RNA level and protein level. 5-ethynyl-2'-deoxyuridine (EdU) assay, transwell assays and flow cytometry analyses were conducted to assess biological behaviors of ESCC cells. Additionally, the interaction between genes were analyzed via Chromatin Immunoprecipitation (ChIP) assay, RNA Binding Protein Immunoprecipitation (RIP) assay, RNA pull down assay and luciferase reporter assay.
RESULTS: MiR-137 was down-regulated in ESCC cells. Upregulation of miR-137 hindered ESCC cell proliferation, migration, invasion and epithelial mesenchymal transition (EMT). Besides, miR-137 enhanced the sensitivity of ESCC cells to irradiation. Moreover, CCCTC-binding factor (CTCF) inactivated miR-137 transcription in ESCC cells. Furthermore, we revealed enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) and paxillin (PXN) as the downstream targets of miR-137. In turn, EZH2 was recruited by CTCF and induced methylation in miR-137 promoter.
CONCLUSION: CTCF/Suz12/EZH2 complex-silenced miR-137 facilitates ESCC progression and radioresistance by targeting EZH2 and PXN.

Entities:  

Keywords:  CTCF; ESCC; EZH2; PXN; miR-137

Year:  2021        PMID: 33685449     DOI: 10.1186/s12935-020-01740-8

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  39 in total

1.  Esophageal cancer.

Authors:  Christian S Hinrichs; Charles W van Way
Journal:  Curr Surg       Date:  2002 Jan-Feb

Review 2.  Repression of protein synthesis by miRNAs: how many mechanisms?

Authors:  Ramesh S Pillai; Suvendra N Bhattacharyya; Witold Filipowicz
Journal:  Trends Cell Biol       Date:  2007-01-02       Impact factor: 20.808

3.  A reply to evidence-based radiation oncology: oesophagus.

Authors:  Richard S Gillies; Mark R Middleton; Claire Blesing
Journal:  Radiother Oncol       Date:  2010-02-01       Impact factor: 6.280

Review 4.  Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries.

Authors:  María José Domper Arnal; Ángel Ferrández Arenas; Ángel Lanas Arbeloa
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 5.  Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role.

Authors:  Parisa Naeli; Mohammad Hossein Pourhanifeh; Mohammad Reza Karimzadeh; Zahra Shabaninejad; Ahmad Movahedpour; Hossein Tarrahimofrad; Hamid Reza Mirzaei; Hassan Hassani Bafrani; Amir Savardashtaki; Hamed Mirzaei; Michael R Hamblin
Journal:  Crit Rev Oncol Hematol       Date:  2019-12-20       Impact factor: 6.312

Review 6.  Stroke in Women: Risk Factors and Clinical Biomarkers.

Authors:  Hamed Mirzaei
Journal:  J Cell Biochem       Date:  2017-06-13       Impact factor: 4.429

7.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

Review 8.  SiRNA and epigenetic aberrations in ovarian cancer.

Authors:  Hamed Mirzaei; Foad Yazdi; Rasoul Salehi; Hamid Reza Mirzaei
Journal:  J Cancer Res Ther       Date:  2016 Apr-Jun       Impact factor: 1.805

Review 9.  Chemopreventive and therapeutic potential of curcumin in esophageal cancer: Current and future status.

Authors:  AmirReza Hesari; Mitra Azizian; Alireza Sheikhi; Abolfazl Nesaei; Shahin Sanaei; Nazanin Mahinparvar; Maryam Derakhshani; Pegah Hedayt; Faezeh Ghasemi; Hamed Mirzaei
Journal:  Int J Cancer       Date:  2018-11-12       Impact factor: 7.396

10.  Identification of long noncoding RNAs dysregulated in the midbrain of human cocaine abusers.

Authors:  Michael J Bannon; Candace L Savonen; Hui Jia; Fabien Dachet; Steven D Halter; Carl J Schmidt; Leonard Lipovich; Gregory Kapatos
Journal:  J Neurochem       Date:  2015-09-01       Impact factor: 5.372

View more
  2 in total

1.  Inhibition of lncRNA RET enhances radio-sensitivity of tumor cells via miR-3179/Slug/PTEN axis.

Authors:  Xinxin Liang; Xueping Li; Ping Wang; Zhongmin Chen; Ziyan Yan; Xingkun Ao; Yuhao Liu; Jiaojiao Zhu; Tingting Xi; Shenghui Zhou; Zhongqiu Li; Chao Li; Maoxiang Zhu; Ping-Kun Zhou; Yongqing Gu
Journal:  Toxicol Res (Camb)       Date:  2022-04-01       Impact factor: 2.680

Review 2.  The long and short non-coding RNAs modulating EZH2 signaling in cancer.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Kiavash Hushmandi; Farid Hashemi; Amirhossein Zabolian; Israel Canadas; Ali Zarrabi; Noushin Nabavi; Amir Reza Aref; Francesco Crea; Yuzhuo Wang; Milad Ashrafizadeh; Alan Prem Kumar
Journal:  J Hematol Oncol       Date:  2022-03-02       Impact factor: 17.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.